Anti-psychotics killer of Alzheimer patients

Peace be with you

Today’s NY Times
ran a story about how anti-psychotics double your chance of dying as an Alzheimer patient.  Clive Ballard, Wolfson Centre for Age-Related Diseases, King’s College London, says ”For the vast majority of Alzheimer’s patients, taking these drugs is probably not a worthwhile risk.”

We previously believed that the treatment of Alzheimer patients didn’t work, but now looking at it from the Nazi euthanasia model I guess it works pretty well.

The New Alzheimer Center is only a quarter of a million dollars shy of the 4.5 million they need to enlarge their drugging net. There is no way I would ever let someone I cared about be roped and doped in the New Alzheimer Center, and believe me when I say “I care about all of you.” Remember the words of Nancy Regan “just say no to Phil Crandall’s Drugs!”

More on this study.

love eternal


One Response to “Anti-psychotics killer of Alzheimer patients”

  1. fig Says:

    Saturday. JAN.10-2009

    MY 2009, PREDICTION: a baseball player on psychiatric drugs (aka “add” drugs)
    will go berserk and kill some number of people a la COLUMBINE,
    VIRGINA TECH and most recently COVINA(Los angeles), Calif.


    People, PSYCHIATRIC DRUGS are wmd in synthetic chemical form.
    people, PSYCHIATRIC DRUGS are wmd in synthetic chemical form.

    Baseball’s 2008 drug test results released in report
    By Bill Shaikin

    The number of players approved for ADD medication rose last year. The public accounting is in response to the Mitchell Report. >>

    Baseball’s 2008 drug test results released in report
    The number of players approved for ADD medication rose last year. The public accounting is in response to the Mitchell Report.
    By Bill Shaikin
    January 10, 2009 — SAT.

    The number of players approved to take attention deficit disorder medications under baseball’s drug policy rose last season, even after the sport tightened its rules in response to criticism from Congress.

    According to a report issued today, 106 therapeutic use exemptions for ADD drugs were issued last year, up from the 103 exemptions reported to Congress in 2007.

    That 8% of players would require ADD medications dismayed Dr. Gary Wadler, a New York physician and adviser to the World Anti-Doping Agency. Wadler said the disorder is diagnosed in 3-5% of children and a smaller percentage of adults.

    “There’s nothing unique that would cause an epidemic of ADD in baseball,” he said.

    Rob Manfred, baseball’s executive vice president of labor relations, said he was unaware of any study that indicated the prevalence of ADD among athletes and said baseball might fund one.

    He said it made little sense to compare the diagnoses of ADD among the general population to those among young male professional athletes with access to high-quality medical care.

    “That’s just stupid,” Manfred said.

    For the first time — and in implementing one of the recommendations in last year’s Mitchell Report — baseball issued a public accounting of how many positive tests had been recorded last year and how many exemptions had been issued.

    Of 3,486 tests administered last year, 19 resulted in a positive test, including five for performance-enhancing substances and 14 for stimulants, according to the report. The tests covered 1,348 players.

    The issue of ADD drugs arose during a Congressional hearing last year, when it was revealed that the number of exemptions granted for those drugs had risen from 28 in 2006 to 103 in 2007, sparking concern that some players might be trying to circumvent a new amphetamine ban by using ADD medications.

    In response, baseball tightened the rules covering exemptions, restricted team doctors from writing prescriptions for ADD drugs and refused to allow players to pursue an exemption after a positive test, even with a prior prescription.

    Manfred said he was “encouraged” that the number of new exemptions — as opposed to renewals — dropped from 72 in 2007 to 56 last year.

    “I think the changes we made have had some effect,” he said. “We will look hard at the process again this offseason.”

    Rep. John Tierney (D-Mass.), who challenged baseball officials on the issue during last year’s hearing, was not available for comment Friday, his office said.

    Rep. Henry Waxman (D-Beverly Hills), whose committee called for that hearing, applauded the public release of test results.

    “I remain concerned about the large number of therapeutic-use exemptions given to players and hope that MLB will look carefully at the process for providing these exemptions,” Waxman said in a statement.

    “But overall, I am pleased with the steps taken by MLB and the players’ union to strengthen their drug testing program and eliminate the use of steroids and other performance enhancing drugs.”

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s